In this systematic review, ten studies reported risk reclassification of prostate cancer with genome classifier testing, with ...

PSMA PET scans enable precise detection of prostate cancer even in its earliest stages, improving diagnostic accuracy and ...

A groundbreaking study has shown that a drug currently being tested for ovarian and bile duct cancer, called NXP800, could ...

Rates of breast and thyroid cancer for women under 50 rose from 2002 to 2021, while men in the same age group had declining ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

New consensus recommendations address implementation of novel treatments and imaging techniques for advanced and ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Prostate cancer cells require large amounts of nutrients. When these run low, GCN2 signals the cells to produce more fuel.